The Best Melasma Treatment in Canada (And Why Most People Are Using the Wrong Things)
Melasma is one of the most frustrating skin conditions to treat. Not because effective treatments don't exist — they do — but because most people spend years using products that were never strong enough to make a meaningful difference.
If you've tried vitamin C serums, niacinamide, kojic acid brighteners, and every "dark spot corrector" on the shelf without real results, this is probably why.
Here's what actually works for melasma in Canada, what doesn't, and how to get access to prescription-strength treatment without spending months on a dermatologist waitlist.
What is melasma, exactly?
Melasma is a form of hyperpigmentation characterized by patches of darker skin, typically appearing on the cheeks, forehead, upper lip, and chin. It's driven by overactive melanocytes — the cells responsible for producing melanin — responding to triggers including UV exposure, hormonal fluctuations, and inflammation.
It's particularly common during pregnancy (sometimes called the "mask of pregnancy"), while using hormonal contraceptives, and during perimenopause — all periods of significant hormonal change. But it can affect anyone, regardless of hormonal status, and is more prevalent in darker skin tones.
The reason melasma is notoriously difficult to treat is structural: it's not a surface discolouration you can exfoliate away. The excess pigment is being actively produced by cells in the deeper layers of the skin, triggered by signals that over-the-counter products typically can't interrupt at a meaningful level.
Why OTC brightening products rarely work for melasma
Walk into any pharmacy or beauty retailer in Canada and you'll find dozens of products claiming to address dark spots and hyperpigmentation. Most of them contain some combination of vitamin C, niacinamide, kojic acid, alpha arbutin, or azelaic acid — all legitimate ingredients with evidence behind them.
The problem isn't the ingredients. It's the concentration.
Over-the-counter products are formulated to be safe for unsupervised use at scale — which means concentrations that are well below what clinical research shows to be most effective. A 2% niacinamide serum and a 10% niacinamide formulation prescribed as part of a clinical protocol are not the same thing, even if the label lists the same ingredient.
There's also the mechanism problem. Most OTC brightening products work on melanin that's already reached the surface — they help fade existing discoloration gradually. But they don't reliably interrupt the melanin production process upstream, which means new pigment continues to form even as old pigment fades.
For melasma specifically, which involves chronic overactivation of melanocytes in response to persistent triggers, surface-level fading is rarely enough on its own.
What actually works for melasma: the prescription approach
Effective melasma treatment requires working at the level of melanocyte activity — not just at the surface. This means prescription-strength actives, clinical oversight, and a protocol that accounts for your specific presentation.
The most effective approach combines multiple mechanisms simultaneously:
A prescription retinoid (tretinoin) accelerates cell turnover, helping existing pigmented cells shed faster while also improving the penetration and efficacy of other actives. Tretinoin alone has clinical evidence for improving melasma, and it forms the foundation of most effective treatment protocols.
Melanocyte-inhibiting actives work upstream of pigment formation. The specific actives depend on your skin tone, melasma severity, and history:
Tranexamic acid — increasingly the preferred first-line active for melasma, particularly for medium and darker skin tones. Blocks the plasminogen pathway that triggers UV-induced melanin production. Well tolerated and effective across Fitzpatrick types.
Azelaic acid — inhibits tyrosinase (the enzyme central to melanin synthesis) while also reducing the inflammation that drives post-inflammatory hyperpigmentation. Dual mechanism makes it particularly useful.
Kojic acid — a naturally-derived tyrosinase inhibitor often used in combination protocols to broaden the treatment approach.
Hydroquinone — the gold-standard prescription depigmenting agent where appropriate. Used in structured cycles under clinician supervision. Highly effective but requires oversight to avoid the ochronosis risk associated with long-term unsupervised use.
The combination matters more than any single ingredient. A protocol that pairs tretinoin with tranexamic acid and azelaic acid, for example, is attacking melasma through three distinct mechanisms simultaneously — cell turnover, melanin synthesis inhibition, and inflammation reduction. This is categorically different from a single brightening serum, regardless of how sophisticated the serum claims to be.
Sun protection is non-negotiable
Any dermatologist or clinician will tell you the same thing: no melasma treatment works without consistent, daily SPF use. UV exposure is one of the primary triggers for melanocyte overactivation — without protection, treatment undoes itself in real time.
This means SPF 30 minimum, every day, regardless of whether you're spending time outdoors. Mineral sunscreens (zinc oxide, titanium dioxide) are generally preferred for melasma patients because they provide broad-spectrum protection without the potential for irritation that some chemical filters cause.
If you're using prescription actives and skipping sunscreen, the treatment will underperform significantly.
How long does melasma treatment take?
Honest answer: longer than most people expect.
Melasma responds more slowly than other forms of hyperpigmentation, and timelines vary significantly based on melasma depth (epidermal melasma responds faster than dermal), skin tone, consistency of treatment, and sun exposure.
Most patients on a proper prescription protocol see meaningful improvement at the 3-month mark, with continued progress through 6–12 months. Some forms of melasma — particularly deep dermal melasma — are more resistant and require longer treatment or maintenance protocols.
Your clinician sets realistic expectations based on your specific presentation. Progress that feels slow is often meaningful progress — melasma treatment is a commitment, not a course.
Getting prescription melasma treatment in Canada without a dermatologist
Dermatologist waitlists in Canada are notoriously long — often 6 months to a year for a non-urgent referral, in cities where referrals are even available. For melasma patients, this is a significant barrier to treatment that actually works.
The alternative is online prescription services staffed by licensed Canadian medical professionals — nurse practitioners and physicians who can assess and prescribe remotely, without an in-person appointment.
At Laevo, the process is:
Complete a skin assessment — your skin history, current concerns, previous treatments, photo of the affected area. Takes 5 minutes.
Clinician review — a licensed Canadian medical professional reviews your case and determines the appropriate combination of actives for your specific melasma presentation and skin tone.
Prescription compounded — your formula is prepared fresh at a licensed Canadian pharmacy using pharmaceutical-grade ingredients, at the concentrations your clinician prescribed.
Delivered every 2 months — with formula adjustments as your skin responds.
The assessment fee covers the clinical review. If approved, your formula ships within days.
What about melasma during pregnancy?
Pregnancy is one of the most common triggers for melasma, and it's also a context that requires careful consideration before any treatment.
Many prescription actives used in melasma treatment — including tretinoin and hydroquinone — are contraindicated during pregnancy and breastfeeding. The Laevo assessment screens for this and will not prescribe contraindicated actives.
For melasma that developed during pregnancy, treatment typically begins postpartum and after breastfeeding has concluded. In many cases, hormonal melasma improves somewhat on its own after delivery — though it often persists and benefits from targeted treatment.
A note on melasma and skin tone
Melasma is more common in medium and darker skin tones, and treatment requires care around which actives are used and at what concentration. Certain approaches that work well for lighter skin tones can cause post-inflammatory hyperpigmentation in darker skin — a frustrating outcome that worsens the original problem.
This is one of the most important reasons clinical oversight matters for melasma treatment specifically. A clinician reviewing your assessment considers your Fitzpatrick skin type when selecting actives and concentrations — something a general skincare product cannot do.
Tranexamic acid and azelaic acid are generally preferred first-line actives for medium and darker skin tones, with hydroquinone used cautiously and in cycles where appropriate.
Start your assessment
If you've been dealing with melasma and OTC products haven't moved the needle, a prescription protocol designed around your specific presentation is the next logical step.
The Laevo assessment takes 5 minutes. A licensed Canadian clinician reviews your skin and designs your formula — tretinoin base plus the appropriate pigment-regulating actives for your skin tone and melasma type.
Assessment fee applies. Prescription required — not all applicants will be approved. Melasma treatment timelines vary. Individual results depend on melasma type, depth, and consistency of treatment and sun protection. This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any prescription treatment.
